7-116778877-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000245.4(MET):c.3442C>T(p.Arg1148*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000684 in 1,461,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000245.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MET | NM_000245.4 | c.3442C>T | p.Arg1148* | stop_gained | Exon 17 of 21 | ENST00000397752.8 | NP_000236.2 | |
MET | NM_001127500.3 | c.3496C>T | p.Arg1166* | stop_gained | Exon 17 of 21 | NP_001120972.1 | ||
MET | NM_001324402.2 | c.2152C>T | p.Arg718* | stop_gained | Exon 16 of 20 | NP_001311331.1 | ||
MET | XM_011516223.2 | c.3499C>T | p.Arg1167* | stop_gained | Exon 18 of 22 | XP_011514525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MET | ENST00000397752.8 | c.3442C>T | p.Arg1148* | stop_gained | Exon 17 of 21 | 1 | NM_000245.4 | ENSP00000380860.3 | ||
MET | ENST00000318493.11 | c.3496C>T | p.Arg1166* | stop_gained | Exon 17 of 21 | 1 | ENSP00000317272.6 | |||
MET | ENST00000436117.3 | n.*1047C>T | non_coding_transcript_exon_variant | Exon 16 of 20 | 1 | ENSP00000410980.2 | ||||
MET | ENST00000436117.3 | n.*1047C>T | 3_prime_UTR_variant | Exon 16 of 20 | 1 | ENSP00000410980.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461760Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727200
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Renal cell carcinoma Uncertain:1
This sequence change creates a premature translational stop signal (p.Arg1166*) in the MET gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MET cause disease. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MET-related conditions. ClinVar contains an entry for this variant (Variation ID: 246639). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R1166* variant (also known as c.3496C>T), located in coding exon 16 of the MET gene, results from a C to T substitution at nucleotide position 3496. This changes the amino acid from an arginine to a stop codon within coding exon 16. While premature stop codons are typically deleterious in nature for tumor suppressor genes, the MET gene is a well described proto-oncogene and the cancer related phenotype is conventionally due to activating mutations. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6050 samples (12100 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.02% (greater than 4500 alleles tested) in our clinical cohort. Since supporting evidence is limited at this time, the clinical significance of p.R1166* remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at